Amanda Missel

Dr. Amanda Missel

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2023 in Prehospital Emergency Care
Verified
Journal Article
Closed access
AMAmanda Missel
Amanda Missel
SDStephen R. Dowker
Stephen R. Dowker
MCMadeline Chiola
Madeline Chiola
JPJodyn Platt
Jodyn Platt
JTJulia Tsutsui
Julia Tsutsui
CFCharles P. Friedman
Charles P. Friedman
Fewer than 10% of individuals who suffer out-of-hospital cardiac arrest (OHCA) survive with good neurologic function. Bystander CPR more than doubles the chance of survival, and telecommunicator-CP...

10 March 2021 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
AMAmanda Missel
Amanda Missel
LSLaura R. Saslow
Laura R. Saslow
DGDina H. Griauzde
Dina H. Griauzde
DMDonna Marvicsin
Donna Marvicsin
ASAnanda Sen
Ananda Sen
XLXuefeng Liu
Xuefeng Liu
Introduction: Chronic inflammation is associated with the development, progression and long-term complications of type 2 diabetes. Hyperglycemia is associated with chronic low-grade inflammation, and thus has become the focus of many screening and treatment recommendations. We hypothesize that insulin may also be associated with inflammation and may be an additional factor to consider in screening and treatment. Methods: This study used National Health and Nutrition Examination Survey data from 2005 to 2010 to analyze the association between fasting insulin and C-reactive protein (CRP). A two-part model was used due to the high number of values reported as 0.1 mg/L. Two models were analyzed, both with and without the addition of waist circumference to other covariates in the model. Results: The final sample included 4527 adults with a mean age of 43.31 years. In the first model, higher fasting insulin was associated with increased odds of CRP > 0.1 mg/L (OR = 1.02, p < .001) and with higher CRP (β = 0.03, p < .001). In the adjusted model, including waist circumference as a covariate, higher fasting insulin was not associated with CRP > 0.1 mg/L (OR = 1.00, p = .307) but the association between higher fasting insulin and higher continuous CRP remained significant (β = 0.01, p = .012). Conclusion: This study found that higher fasting insulin is associated with higher CRP. These results suggest that treatment approaches that simultaneously decrease insulin levels as well as glucose levels may provide additive anti-inflammatory effects, and therefore may improve long-term outcomes for adults with type 2 diabetes.

24 February 2023 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
AMAmanda Missel
Amanda Missel
JDJohn P. Donnelly
John P. Donnelly
JTJulia Tsutsui
Julia Tsutsui
NWNicholas Wilson
Nicholas Wilson
CFCharles Friedman
Charles Friedman
JCJames M. Cooke
James M. Cooke

9 September 2020 in JMIR Diabetes
Verified
Journal Article
Open access
LSLaura R Saslow
Laura R Saslow
JMJudith Tedlie Moskowitz
Judith Tedlie Moskowitz
AMAshley Mason
Ashley Mason
JDJennifer Daubenmier
Jennifer Daubenmier
BLBradley Liestenfeltz
Bradley Liestenfeltz
FHFrederick M Hecht
Frederick M Hecht
Background: Adults with type 2 diabetes may experience health benefits, including glycemic control and weight loss, from following a very low–carbohydrate, ketogenic (VLC) diet. However, it is unclear which ancillary strategies may enhance these effects. Objective: This pilot study aims to estimate the effect sizes of 3 intervention enhancement strategies (text messages, gifts, and breath vs urine ketone self-monitoring) that may improve outcomes of a 12-month web-based ad libitum VLC diet and lifestyle intervention for adults with type 2 diabetes. The primary intervention also included other components to improve adherence and well-being, including positive affect and mindfulness as well as coaching. Methods: Overweight or obese adults (n=44; BMI 25-45 kg/m2) with type 2 diabetes (glycated hemoglobin [HbA1c] ≥6.5%), who had been prescribed either no glucose-lowering medications or metformin alone, participated in a 12-month web-based intervention. Using a 2×2×2 randomized factorial design, we compared 3 enhancement strategies: (1) near-daily text messages about the intervention’s recommended behaviors (texts n=22 vs no texts n=22), (2) mailed gifts of diet-relevant foods and cookbooks (6 rounds of mailed gifts n=21 vs no gifts n=23), and (3) urine- or breath-based ketone self-monitoring (urine n=21 vs breath n=23). We assessed HbA1c and weight at baseline and at 4, 8, and 12 months. We evaluated whether each strategy exerted a differential impact on HbA1c and weight at 12 months against an a priori threshold of Cohen d of 0.5 or greater. Results: We retained 73% (32/44) of the participants at 12 months. The intervention, across all conditions, led to improvements in glucose control and reductions in body weight at the 12-month follow-up. In intent-to-treat (ITT) analyses, the mean HbA1c reduction was 1.0% (SD 1.6) and the mean weight reduction was 5.3% (SD 6.0), whereas among study completers, these reductions were 1.2% (SD 1.7) and 6.3% (SD 6.4), respectively, all with a P value of less than .001. In ITT analyses, no enhancement strategy met the effect size threshold. Considering only study completers, 2 strategies showed a differential effect size of at least a d value of 0.5 or greater Conclusions: Text messages, gifts of food and cookbooks, and urine-based ketone self-monitoring may potentially enhance the glycemic or weight loss benefits of a web-based VLC diet and lifestyle intervention for individuals with type 2 diabetes. Future research could investigate other enhancement strategies to help create even more effective solutions for the treatment of type 2 diabetes. Trial Registration: ClinicalTrials.gov NCT02676648; http://clinicaltrials.gov/ct2/show/NCT02676648

4 September 2021 in F&S Reports
Verified
Journal Article
Open access
AMAmanda Missel
Amanda Missel
AOAlison Virginia O’bRien
Alison Virginia O’bRien
HMHaley Maser
Haley Maser
AKAmreen Kanwal
Amreen Kanwal
HBHovig Bayandorian
Hovig Bayandorian
LSLaura R. Saslow
Laura R. Saslow
To study the impact of a very-low-carbohydrate (VLC) diet for 16 weeks in overweight or obese women with polycystic ovary syndrome (PCOS). Single-arm prospective pilot study. We recruited participants using medical records from an academic medical center. Twenty-nine overweight or obese women (body mass index, 25–50 kg/m2) with PCOS. We taught participants to follow a VLC diet and provided information about a variety of behavioral skills including mindfulness and positive affect using an online 16-week intervention. Changes in body weight, glycated hemoglobin, and PCOS-related quality of life. The intervention led to positive health outcomes including decreases in percent weight (mean difference = −7.67, SD = 6.10) and glycated hemoglobin level (mean difference = −0.21%, SD = 0.27), an increase in sex hormone binding globulin level (mean difference = 9.24 nmol/L, SD = 16.34), and increases in PCOS-related quality of life measures, including menstrual predictability (mean difference = 2.10, SD = 2.76) and body hair (mean difference = 1.14, SD = 1.04). The low-density lipoprotein cholesterol level increased (mean difference = 0.23 mmol/L, SD = 0.49). The results suggest that a VLC dietary intervention has potential to promote both weight loss and glycemic control in overweight and obese adults with PCOS, two key components in the prevention of type 2 diabetes. NCT03987854.

3 May 2023 in Resuscitation
Verified
Journal Article
Closed access
AMAmanda Missel
Amanda Missel
CDChristopher J. Drucker
Christopher J. Drucker
KKKosuke Kume
Kosuke Kume
JSJenny Shin
Jenny Shin
LHLindsey Hergert
Lindsey Hergert
TRThomas Rea
Thomas Rea